GlassScriptPhysician profile
Kenneth P Seiter
NPI 1316150949
$46,142.32
in general payments reported to CMS, 2019-2025
32 companies · $16K in 2025
The $16K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,826 · 2020: $415 · 2021: $5,920 · 2022: $6,749 · 2023: $1,020 · 2024: $11K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $5,937 · Royalty Or License: $4,807 · Food and Beverage: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,762.50 |
| Travel and Lodging | $5,937.23 |
| Royalty Or License | $4,806.98 |
| Food and Beverage | $1,725.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vilex LLC | $14,599.96 | 2022-2025 | Titanex, Charcot |
| Medline Industries LP | $13,690.30 | 2019-2025 | Medline Industries, INC., Medline, Medline Unite |
| Crossroads Extremity Systems, LLC | $5,548.67 | 2021 | |
| Wright Medical Technology, INC. | $5,118.60 | 2019-2020 | |
| Extremity Medical | $3,941.88 | 2024-2025 | |
| Stryker Corporation | $983.55 | 2019-2025 | Inbone, Easyfuse, Infinity |
| Midsouth Orthopedics INC. | $330.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $253.49 | 2021-2023 | Tapestry |
| Kerecis Limited | $191.08 | 2022 | |
| Depuy Synthes Sales INC. | $174.42 | 2019-2025 | Motoband |
| Smith+Nephew, INC. | $167.74 | 2019-2025 | Stravix, Oasis, Grafix |
| Averitas Pharma INC. | $139.44 | 2023-2025 | Qutenza |
| Abbvie INC. | $138.33 | 2022-2024 | Dalvance |
| Horizon Therapeutics Plc | $127.70 | 2019-2023 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $92.10 | 2022-2023 | Seglentis |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $84.94 | 2024 | |
| Paratek Pharmaceuticals, INC. | $73.73 | 2022-2023 | Nuzyra |
| Melinta Therapeutics, LLC | $60.30 | 2019 | |
| Zyla Life Sciences, INC. | $60.09 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.84 | 2021-2022 | |
| Polynovo North America LLC | $54.28 | 2023-2025 | Novosorb Btm |
| In2bones USA, LLC | $37.13 | 2021 | |
| Medtronic, INC. | $37.01 | 2023 | Intellis Adaptivestim |
| Innovation Technologies INC | $35.70 | 2023 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $22.57 | 2025 | Exparel |
| Stimwave Technologies Incorporated | $22.27 | 2022 | |
| Nabriva Therapeutics, Plc | $21.58 | 2022 | |
| Bone Support INC. | $17.60 | 2024 | Ceramentbone Void Filler, Cerament G |
| Bioventus LLC | $17.35 | 2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $15.72 | 2024 | |
| Merck Sharp & Dohme LLC | $14.81 | 2019 | |
| Alfasigma USA, INC. | $14.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Seiter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.